ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Upton Closer To Decision On Control, Centers Merger; ACCC Defeats Motion In Opposition

March 16, 1979

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

New Jersey Center To Have Two Alliances: One With CINJ—and One With MD Anderson

June 21, 2013